Beyond seizures: Comprehensive care approach for Lennox-Gastaut syndrome

Beyond seizures: A multidimensional approach to non-seizure issues in Lennox-Gastaut syndrome. Insights from Italian experts.

Epilepsia open • • Review • Moderately Relevant
🤖

AI Summary

Lennox-Gastaut syndrome (LGS) is a severe form of epilepsy where non-seizure issues often matter more than seizure control itself. These include problems with cognition, behavior, sleep, movement, and daily living skills that significantly impact patients' quality of life. Rather than only counting seizures, clinicians need a comprehensive approach to assess how these broader issues affect patients throughout their lives. This research proposes a practical framework that healthcare teams can actually use in regular clinic visits to monitor these critical aspects of patient wellbeing.

The paper presents a clinic-ready assessment system that combines clinician observations with input from caregivers and teachers to create a more complete picture of patient health. The framework recommends regular conversations about non-seizure issues at every visit, with more formal assessments scheduled strategically—typically every 6-12 months for behavior and sleep, and annually for cognition and adaptive skills. Importantly, the approach personalizes care based on each patient's developmental stage, comorbidities, and family context rather than applying a one-size-fits-all approach.

Notably, the paper mentions emerging evidence that cannabidiol and fenfluramine may offer benefits beyond seizure reduction, potentially improving alertness, behavior, sleep, and communication in LGS patients. However, the authors emphasize that LGS-specific evidence for these treatments remains preliminary. The research agenda calls for better outcome assessment tools that capture meaningful changes and incorporate patient and caregiver perspectives, moving LGS care toward a focus on participation, resilience, and quality of life rather than seizure counts alone.

📄 Original Abstract

Non-seizure issues (NSIs), including cognition, behavior/psychiatric symptoms, adaptive and social functioning, sleep, autonomic, and motor impairments, often shape day-to-day outcomes in Lennox-Gastaut syndrome (LGS) more than seizures, yet clinicians lack LGS-specific, feasible assessment pathways. An expert panel synthesized evidence and clinical experience to propose a lifespan, clinic-ready framework that pairs clinician-administered measures with caregiver/teacher reports and uses brief global impressions from both clinicians and caregivers to detect meaningful change. The framework emphasizes continuous, structured conversations about NSIs at every visit, with standardized tools deployed less frequently in line with the properties of instrument re-administration and local resources. As a pragmatic guide, behavior/sleep are typically reviewed every 6-12 months, and cognition/adaptive skills are reviewed annually. Rather than prescribing a universal "minimum battery" the approach prioritizes personalization to developmental stage, comorbidities, disability level, and family context. The Discussion also integrates therapeutic considerations: Early data suggest fenfluramine and cannabidiol may benefit alertness, behavior, sleep, and communication beyond seizure reduction, while acknowledging that LGS-specific evidence remains preliminary. Key gaps include the limited validation of instruments in LGS, the scarcity of adult-focused measures (e.g., biopsychosocial frailty), and tools that are insufficiently sensitive to small but meaningful changes. We outline a research agenda for co-designed clinical outcome assessments that combine quantitative scales with qualitative insights from patients, caregivers, and teachers. Centering NSIs and feasible follow-up, this work offers a practical route to move LGS care beyond seizure counts toward participation, resilience, and quality of life for patients and families. PLAIN LANGUAGE SUMMARY: People with Lennox-Gastaut syndrome often struggle with problems beyond seizures, such as learning, behavior, sleep, movement, and daily living skills. These non-seizure issues can affect quality of life even more than seizure counts. We propose a practical, clinic-ready approach to check these issues across all ages using brief clinician assessments plus caregiver and teacher input. Regular conversations at each visit, with targeted questionnaires every 6-12 months or yearly, can help detect meaningful changes and guide care.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.